XU JIANDONG (Chief Financial Officer) purchased 0.8% of their position (2.10K shares) of ESTRELLA IMMUNOPHARMA, INC. on the open market
Open‑market purchase worth $2.6K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 4/30/2026ACC: 0001213900-26-049602
Officer· Chief Financial Officer
Since Sep 2023
+2.10K
Net shares
Net buyer
$2.6K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
2.10K acquired
Non-Derivative Transactions3
Common Stock, par value $0.0001 per share
Direct
Shares
+100.00
Price / share
$1.04
Trade value
$104.00
% of position
0.0%
9/11/2025
264.49K→264.59K
Common Stock, par value $0.0001 per share
Indirect
Shares
+1K
Price / share
$1.16
Trade value
$1.16K
% of position
6.4%
9/22/2025
15.70K→16.70K
Common Stock, par value $0.0001 per share
Direct
Shares
+1K
Price / share
$1.33
Trade value
$1.33K
% of position
0.4%
10/7/2025
264.49K→265.49K
Total
Net shares
+2.10K
Net value
$2.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 9/11/2025 | P · Purchase | +100.00 | $1.04 | $104.00 | 0.0% | 264.49K | 264.59K |
| Common Stock, par value $0.0001 per share Indirect | 9/22/2025 | P · Purchase | +1K | $1.16 | $1.16K | 6.4% | 15.70K | 16.70K |
| Common Stock, par value $0.0001 per share Direct | 10/7/2025 | P · Purchase | +1K | $1.33 | $1.33K | 0.4% | 264.49K | 265.49K |
| Total | +2.10K | $2.59K | ||||||
Derivative Transactions0
No derivative transactions reported